Search

everythinglearnresearchcommunity

for

Search:↓

People with alopecia areata have a higher risk of depression and anxiety, and often face unemployment and work absences.

Children's hair loss can be caused by various factors and should be treated with appropriate, age-specific methods and psychological support.

Blocking JAK/STAT pathways can help treat hair loss from alopecia areata.

Alopecia areata shows a unique type 1 interferon signature, suggesting potential treatment by targeting this pathway.

Anti-Ro exposed children had more reported neuro-psychiatric issues, but differences from healthy controls were not significant.

New JAK inhibitor drugs show promise for treating skin diseases but need more research on safety and effectiveness.

Some drugs used to treat immune conditions may cause different types of hair loss.

Papulopustular rosacea is an inflammatory skin condition treatable with lifestyle changes and medications.

Topical corticosteroids are the main treatment for Erosive Pustular Dermatosis, but recurrence is common after stopping treatment.

Thyroid problems can cause hair loss and change hair texture.

Ustekinumab significantly improved psoriasis, vitiligo, and alopecia areata in a patient.

Alopecia is linked to various health and mental conditions, impacts life quality, and needs medical attention beyond its cosmetic effects.

The document concludes that diagnosing and treating hair loss is complex and requires understanding its psychological effects and underlying causes, while also calling for more research and new treatments.

Targeted therapies for lung cancer are effective but require careful management of side effects to benefit patients.

Seven patients were misdiagnosed with discoid lupus instead of lichen planopilaris due to similar symptoms, showing the need for careful diagnosis in scarring hair loss conditions.

The document concludes that diagnosing female hair loss requires careful examination, with treatments varying by condition and psychological support often necessary.

Most alopecia areata patients in the study were women, aged 15-49, with patchy hair loss and often had other health conditions.

Tildrakizumab showed limited effectiveness in treating chronic alopecia areata in a small group of patients.

A patient with alopecia areata regrew hair after taking tofacitinib and showed changes in certain blood and skin markers.

Topical prostaglandin analogs may help with hair growth but more research is needed.

The document concludes that accurate diagnosis and appropriate management are crucial for treating various hair disorders, which have significant psychological impacts.

New targeted therapies for hair loss from alopecia areata show promise, with personalized treatment expected in the future.

Low-dose naltrexone helps reduce symptoms and slow down lichen planopilaris without side effects.

Premature graying of hair is common and stressful, but not well understood or treated.

Men with common hair loss may have a higher risk of heart disease and diabetes, and should be checked for these conditions.

An 11-year-old boy in Saudi Arabia has a rare case of hypoparathyroidism with severe brain calcifications but normal development and no known cause.

A man with complete hair loss and ulcerative colitis regrew hair after treatment with azathioprine.

Using low-dose IL-2 to increase regulatory T cells might be a safe way to treat type 1 diabetes without severe side effects.

Certain IL-18 gene variations may increase the risk of alopecia areata.

New protein changes may be involved in the immune attack on hair follicles in alopecia areata.